Back to questions
**Innovation through collaboration: How pediatric cancers and partnered platforms like precisionFDA are teaching us to “compete to share” in biomedicine's digital economy of technology and culture of ownership.**
Adam Resnick, PhD
Children's Hospital of Philadelphia
The views expressed are those of the author(s) and should not be construed to represent views or policies held by the FDA.